Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Alberta Health services200 enrolled

Overview

A study of pharmacokinetics of daily intravenous busulfan

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Sex: ALLMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients undergoing transplantation Exclusion Criteria: \-

Tom Baker Cancer Centre

Calgary, Alberta, Canada

RECRUITING

pharmacokinetic data

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.